Literature DB >> 7204560

Transport of apolipoproteins A-I and A-II by human thoracic duct lymph.

D W Anderson, E J Schaefer, T J Bronzert, F T Lindgren, T Forte, T E Starzl, G D Niblack, L A Zech, H B Brewer.   

Abstract

The daily transport of human plasma apolipoproteins A-I and A-II, triglyceride, and total cholesterol from the thoracic duct lymph into plasma was measured in two subjects before and three subjects after renal transplantation. Lymph triglyceride transport was approximately 83% of the daily ingested fat loads, whereas lymph cholesterol transport was consistently greater than the amount of daily ingested cholesterol. Lymph apolipoprotein transport significantly (P < 0.05) exceeded the predicted apolipoprotein synthesis rate by an average of 659+/-578 mg/d for apolipoprotein A-I and 109+/-59 mg/d for apolipoprotein A-II among the five subjects. It is estimated that 22-77% (apolipoprotein A-I) and 28-82% (apolipoprotein A-II) of daily total body apolipoprotein synthesis takes place in the intestine. Lymph high density lipoprotein particles are mostly high density lipoprotein(2b) and high density lipoprotein(2a) and have a greater overall relative triglyceride content and a smaller relative cholesteryl ester content when compared with homologous plasma high density lipoproteins. The major quantity of both lymph apolipoprotein A-I (81+/-8%) and apolipoprotein A-II (90+/-11%) was found within high density lipoproteins with almost all of the remainder found in chylomicrons and very low density lipoproteins. The combined results are consistent with a major contribution of the intestine to total body synthesis of apolipoprotein A-I and apolipoprotein A-II. An important role of lymph in returning filtered apolipoprotein to plasma in association with high density lipoproteins is proposed. Accompanying the return of filtered apolipoprotein to the plasma is a probable transformation, both in size and composition, of at least some of the lymph high density lipoprotein(2b) and high density lipoprotein(2a) particles into high density lipoprotein(3).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204560      PMCID: PMC370637          DOI: 10.1172/jci110103

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine.

Authors:  H G Windmueller; P N Herbert; R I Levy
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

2.  [Studies on the composition of the lipoproteins in human lymph].

Authors:  G Kostner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-12

Review 3.  Application of electron microscopy to the study of plasma lipoprotein structure.

Authors:  T Forte; A V Nichols
Journal:  Adv Lipid Res       Date:  1972

4.  Characterization and quantitation of the apolipoproteins from human chyle chylomicrons.

Authors:  G Kostner; A Holasek
Journal:  Biochemistry       Date:  1972-03-28       Impact factor: 3.162

5.  Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex.

Authors:  H B Brewer; S E Lux; R Ronan; K M John
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Isolation and characterization of human chyle chylomicrons and lipoproteins.

Authors:  P Alaupovic; R H Furman; W H Falor; M L Sullivan; S L Walraven; A C Olson
Journal:  Ann N Y Acad Sci       Date:  1968-11-21       Impact factor: 5.691

Review 8.  The analysis of human serum lipoprotein distributions.

Authors:  A M Ewing; N K Freeman; F T Lindgren
Journal:  Adv Lipid Res       Date:  1965

9.  Determination of lipid phosphorus in the nanomolar range.

Authors:  A Chalvardjian; E Rudnicki
Journal:  Anal Biochem       Date:  1970-07       Impact factor: 3.365

10.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

View more
  5 in total

1.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.

Authors:  C S Shelley; F E Baralle
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

3.  Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer.

Authors:  M A Lucero; D Sanchez; A R Ochoa; F Brunel; G N Cohen; F E Baralle; M M Zakin
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

4.  Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).

Authors:  L L Kay; R Ronan; E J Schaefer; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins.

Authors:  Maud Chétiveaux; Mikaël Croyal; Khadija Ouguerram; Fanta Fall; Laurent Flet; Yassine Zair; Estelle Nobecourt; Michel Krempf
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.